Every year, Vietnam records more than 10,000 cases of leukemia.

(Dan Tri) - The number of hematological cancers accounts for about 5.8% of new cancer cases. The blood cancer group is estimated to cause about 7,331 deaths, accounting for 6.1% of total cancer deaths.

On August 9, at a scientific conference updating the diagnosis and treatment of some hematological diseases, Associate Professor, Dr. Nguyen Tuan Tung, Deputy Director of Bach Mai Hospital, said that the number of hematological diseases is increasing rapidly worldwide.

In the US, each year there are more than 60,000 new cases of malignant blood diseases such as acute myeloid leukemia, multiple myeloma, lymphoma, etc.; in Europe, acute myeloid leukemia has a 5-year survival rate of only about 25-30%.

In Vietnam, there are approximately more than 10,000 cases of hematological cancer recorded each year, accounting for 5.8% of total cancer cases.

According to Associate Professor Tung, hematological diseases, from benign to malignant, have diverse clinical manifestations, easily overlapping with symptoms of many other specialties, making diagnosis and treatment complicated. Many cases are detected at a late stage, leading to difficulties in prognosis and long-term management.

Many hematological diseases such as multiple myeloma, lymphoma, myelofibrosis, etc. also tend to increase, especially in middle-aged and elderly people. Cutaneous lymphoma or other rare forms can develop silently for decades and can be easily missed if not examined by a specialist.

Experts say that many cases of hematological cancer are detected at a late stage, leading to difficulties in prognosis and long-term management (Photo: The Anh).

Speaking at the conference, Associate Professor, Dr. Dao Xuan Co, Director of Bach Mai Hospital, said that the hospital is focusing its resources on implementing cell therapy, gene therapy, new generation targeted drugs, expanding stem cell transplantation; at the same time, developing genetic testing techniques, molecular biology and applying AI and big data in diagnosing and treating hematological diseases.

"New methods such as targeted drugs, immunotherapy and hematopoietic stem cell transplantation have been implemented and brought positive results. After more than 10 years, the Hospital has successfully performed 142 transplants, helping many patients recover and have a chance to live longer. There is a case of leukemia that was treated at the age of 21, now has a family and healthy children," Associate Professor Co informed.

Meanwhile, the cost of stem cell transplantation in Vietnam is much lower than abroad, only about 40-50 million VND after support from the Social Insurance Fund (abroad it can be up to 2-6 billion VND).

Worldwide , gene therapy has been approved by the US FDA to treat a number of hematological diseases such as thalassemia, hemophilia and some cancers.

Source: https://dantri.com.vn/suc-khoe/moi-nam-viet-nam-ghi-nhan-hon-10000-ca-ung-mau-20250809180903908.htm